Hot Stocks: NVDA drops on preliminary results; MNDY, TGTX rally; SGFY climbs on takeover report
Diego Thomazini


Nvidia (NASDAQ:NVDA) drew significant attention during Monday's midday trading. The semiconductor bellwether dropped after reporting disappointing preliminary results.
Elsewhere, earnings-related news had the opposite impact on monday.com (MNDY). The stock rallied on the back of Street-beating financial figures.
TG Therapeutics (TGTX) saw midday gains as well, fueled by quarterly results and hope for regulatory approval for the firm's MS drug. Meanwhile, Signify Health (SGFY) jumped on reports of takeover interest from CVS (CVS).
Gainers
A strong earnings report prompted buying in monday.com (MNDY). Shares jumped nearly 19% after releasing a narrower-than-expected Q2 loss.
The maker of work management software reported revenue that rose 75% from last year. The company also gave an upbeat forecast, saying it projects a top-line total between $130M and $131M. Analysts were targeting $126M.
TG Therapeutics (TGTX) also showed strength in the wake of its quarterly update. Shares soared 17% in midday trading.
The company topped expectations with a narrower Q2 loss. TGTX added that the rest of its fiscal year will be focused on gaining regulatory approval for ublituximab, a potential treatment for relapsing forms of multiple sclerosis. A decision from the U.S. Food and Drug Administration is targeted for late December.
Signify Health (SGFY) represented another major intraday gainer. Shares jumped almost 16% after the Wall Street Journal reported that CVS Health (CVS) is interested in purchasing the home healthcare company.
Decliner
Nvidia (NVDA) dropped almost 9% after the semiconductor company revealed weak preliminary Q2 results. The company said it will report a revenue figure of $6.7B, a decline of 19% from last year and below the $8.1B that analysts were predicting.
NVDA pointed to weakness in its gaming business for the shortfall. The company said this division brought in $2.04B in Q2, down 33% from the previous year.

To keep up with Wall Street's best- and worst-performing stocks throughout the session, turn to Seeking Alpha's On The Move section.